Markets

Omeros Corporation has rescheduled its conference call to January 7, 2026, at 4:30 p.m. ET to discuss the FDA approval and upcoming U.S. launch of YARTEMLEA® on January 2, 2026. YARTEMLEA® is the first and only treatment for hematopoietic stem cell transplant-associated thrombotic microangiopathy (TA-TMA). The call will provide details on this significant milestone.

Brookfield Real Assets Income Fund declared its Q1 2026 monthly distribution schedule, maintaining a consistent $0.1180 per share payout. Key dates for January, February, and March 2026 distributions are detailed, with payments expected later in each respective month. Investors should be aware that a portion of these distributions may be classified as a return of capital, impacting tax planning. Final tax characterization will be available on Form 1099-DIV.

Fitell Corporation is returning capital to shareholders through a dual strategy: an interim cash dividend of $0.10 per share and a one-time Shareholder Loyalty Program offering up to an additional $0.15 per share. These initiatives reflect management’s confidence in the company’s financial health and diversified operations, spanning fitness equipment, treasury management, and robotics. The program aims to incentivize long-term investment, with payments contingent on holding periods.

Intelligent Living Application Group Inc. (ILAG) shareholders approved a share consolidation to boost its stock price and maintain its Nasdaq listing. A 1-for-10 reverse stock split, effective December 30, 2025, will reduce the number of outstanding shares. This move is crucial for complying with Nasdaq’s minimum bid price rule, ensuring continued market participation for the Hong Kong-based lockset manufacturer.

Calvin B. Taylor Bankshares reported strong Q3 2025 results, with net income reaching $4.2 million and year-to-date net income climbing 23.3% to $11.8 million. This growth was driven by a 17.6% increase in net interest income, alongside 8.2% loan growth and 6.0% deposit growth. The bank surpassed $1 billion in assets and maintains robust capital ratios. A new stock repurchase program, allowing for up to 10% of outstanding shares, has been authorized.

374Water is partnering with Cedar Rapids to pilot its AirSCWO system for destroying PFAS in municipal biosolids, aiming for a cleaner waste management solution. The project begins in Q1 2026, with results expected by Q2. This initiative seeks to offer a superior alternative to current methods, addressing growing concerns over “forever chemicals” and potentially validating 374Water’s technology for wider adoption in the wastewater sector.

TechCreate Group Ltd. reported a revenue increase of 10.4% to S$1.9 million in H1 2025, driven by a strategic shift to higher-margin professional services. The company achieved a significant improvement in gross profit margins to 70.5% and narrowed its net loss to S$20,000. TechCreate also successfully completed its IPO in October 2025, raising approximately $11.73 million.

OBOOK Holdings has rescheduled its H1 2025 earnings call to December 29th. This follows recent strategic updates, including a Visa partnership for OwlPay Cash and growth figures for OwlNest. Investors will be keen to see quantitative results validating these initiatives and OBOOK’s blockchain strategy during the call.

MediaTek and DENSO are collaborating to develop advanced System-on-Chips (SoCs) for next-generation autonomous driving. This partnership combines DENSO’s automotive safety expertise with MediaTek’s cutting-edge processor technology. The resulting platform will focus on high AI compute capabilities, enhanced perception for driver assistance, and strict automotive safety standards, aiming to accelerate the development and time-to-market for intelligent mobility solutions.

Leifras Co., Ltd., a children’s sports education company recently listed on NASDAQ, has secured a ¥2.5 billion yen commitment line facility from Chikuho Bank and Mizuho Bank. This funding will support Leifras’s global expansion, focusing on its “Changing and Designing Sports” philosophy and leveraging growing international interest in children’s non-cognitive development. The company plans to adapt its programs and pursue strategic acquisitions to enhance holistic child development worldwide.